Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Dermatology

Journal Scan / Research · July 21, 2016

Efficacy and Safety of Crisaborole Ointment for Atopic Dermatitis

Journal of the American Academy of Dermatology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Sarah Chamlin MD

Journal of the American Academy of Dermatology
Efficacy and Safety of Crisaborole Ointment, a Novel, Nonsteroidal Phosphodiesterase 4 (PDE4) Inhibitor for the Topical Treatment of Atopic Dermatitis (AD) in Children and Adults
J Am Acad Dermatol 2016 Jul 07;[EPub Ahead of Print], AS Paller, WL Tom, MG Lebwohl, RL Blumenthal, M Boguniewicz, RS Call, LF Eichenfield, DW Forsha, WC Rees, EL Simpson, MC Spellman, LF Stein Gold, AL Zaenglein, MH Hughes, LT Zane, AA Hebert

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated